In PC patients with primary disease only, the CD14+ cells in the blood have a high HLA-DR expression but these cells only obtain MDSC phenotypic markers when they infiltrate the tumor (Fig. 4d). This evidence concerns the gene CD14 and pachyonychia congenita.